NSPc1 is a cell growth regulator that acts as a transcriptional repressor of p21Waf1/Cip1 via the RARE element

被引:34
|
作者
Gong, Yanhua
Yue, Jiping
Wu, Xudong
Wang, Xu
Wen, Jianyan
Lu, Lifang
Peng, Xiaozhong [1 ]
Qiang, Boqin
Yuan, Jiangang
机构
[1] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100005, Peoples R China
[2] Peking Union Med Coll, Natl Human Genome Ctr, Beijing 1000005, Peoples R China
[3] Shanghai Genom Inc, Shanghai 201203, Peoples R China
关键词
D O I
10.1093/nar/gkl834
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mammalian polycomb group proteins play an important role in cell cycle control and tumorigenesis. Nervous system polycomb 1 (NSPc1) is a newly identified transcription repressor, highly homologous with PcG protein Bmi-1. In this article, we showed that NSPc1 could promote tumor cell cycle progression and cell proliferation. Semi-quantitative RT-PCR showed that NSPc1 did not affect the expression levels of most Cyclin-depentent kinases (CDK) inhibitors except for p21Waf1/Cip1. Repression activity assays, chromatin immunoprecipitation (ChIP) and DNA pulldown assays all verified that NSPc1 represses the expression of p21Waf1/Cip1 by binding to the (-1357 to -1083) region of the p21Waf1/Cip1 promoter in vivo, and the repression effect is dependent on the retinoid acid response element (RARE element) within the above region of the p21Waf1/Cip1 promoter. Further analysis showed that NSPc1 could compete the RARE element site with RA receptors both in vitro and in vivo. Taken together, our results support the hypothesis that NSPc1 has a positive role in tumor cell growth by down-regulating p21Waf1/Cip1 via the RARE element, which directly connects transcriptional repression of PcGs to CDKIs and RA signaling pathways.
引用
收藏
页码:6158 / 6169
页数:12
相关论文
共 50 条
  • [31] Ets-1 protects vascular smooth muscle cells from undergoing apoptosis by activating p21WAF1/Cip1 -: Ets-1 regulates basal and inducible p21WAF1/Cip1 transcription via distinct cis-acting elements in the p21WAF1/Cip1 promoter
    Zhang, CL
    Kavurma, MM
    Lai, A
    Khachigian, LM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (30) : 27903 - 27909
  • [32] Prohibitin-2 is a novel regulator of p21WAF1/CIP1 induced by depletion of γ-glutamylcyclotransferase
    Taniguchi, Keiko
    Matsumura, Kengo
    Kageyama, Susumu
    Ii, Hiromi
    Ashihara, Eishi
    Chano, Tokuhiro
    Kawauchi, Akihiro
    Yoshiki, Tatsuhiro
    Nakata, Susumu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 496 (01) : 218 - 224
  • [33] MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53
    Zhang, Z
    Wang, H
    Li, M
    Agrawal, S
    Chen, XB
    Zhang, RW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (16) : 16000 - 16006
  • [34] Subcellular localization and transcriptional repressor activity of HBx on p21WAF1/Cip1 promoter is regulated by ERK-mediated phosphorylation
    Noh, EJ
    Jung, HJ
    Jeong, G
    Choi, KS
    Park, HJ
    Lee, CH
    Lee, JS
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 319 (03) : 738 - 745
  • [35] Interferon Regulatory Factor 1 (IRF-1) induces p21WAF1/CIP1 dependent cell cycle arrest and p21WAF1/CIP1 independent modulation of survivin in cancer cells
    Armstrong, Michaele J.
    Stang, Michael T.
    Liu, Ye
    Gao, Jinbo
    Ren, Baoguo
    Zuckerbraun, Brian S.
    Mahidhara, Raja S.
    Xing, Quanhua
    Pizzoferrato, Eva
    Yim, John H.
    CANCER LETTERS, 2012, 319 (01) : 56 - 65
  • [36] Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression
    Kralj, M
    Husnjak, K
    Körbler, T
    Pavelic, J
    CANCER GENE THERAPY, 2003, 10 (06) : 457 - 467
  • [37] The role of p21Waf1/CIP1 as a Cip/Kip type cell-cycle regulator in oral squamous cell carcinoma (Review).
    Perez-Sayans, Mario
    Suarez-Penaranda, Jose-Manuel
    Gayoso-Diz, Pilar
    Barros-Angueira, Francisco
    Gandara-Rey, Jose-Manuel
    Garcia-Garcia, Abel
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2013, 18 (02): : E219 - E225
  • [38] Growth arrest by the LKB1 tumor suppressor:: induction of p21WAF1/CIP1
    Tiainen, M
    Vaahtomeri, K
    Ylikorkala, A
    Mäkelä, TP
    HUMAN MOLECULAR GENETICS, 2002, 11 (13) : 1497 - 1504
  • [39] p21WAF1/CIP1 gene transcriptional activation exerts cell growth inhibition and enhances chemosensitivity to cisplatin in lung carcinoma cell
    Junxia Wei
    Jiang Zhao
    Min Long
    Yuan Han
    Xi Wang
    Fang Lin
    Jihong Ren
    Ting He
    Huizhong Zhang
    BMC Cancer, 10
  • [40] Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression
    Marijeta Kralj
    Koraljka Husnjak
    Tajana Körbler
    Jasminka Pavelić
    Cancer Gene Therapy, 2003, 10 : 457 - 467